19th December 2019
USADA announced today that Priscila Cachoeira Gomes da Silva, of Rio de Janeiro, Brazil, has accepted a four-month sanction for a violation of the UFC Anti-Doping Policy after testing positive for a prohibited substance.
Cachoeira, 31, tested positive for hydrochlorothiazide (HCTZ) and its metabolites chlorothiazide and 4amino-6chloro-1,3-benzenedisulfonamide (ACB) as the result of an out-of-competition urine sample she provided on October 12, 2019. These substances are Specified Substances in the class of Diuretics and Masking Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
During USADA’s investigation into the circumstances of the positive test, Cachoeira provided evidence that the prohibited substance detected in her sample was from a blood pressure medication given to her by her parent in response to symptoms she was experiencing. Cachoeira did not have or apply for a Therapeutic Use Exemption, which is required to authorize the use of a prohibited substance in sport. Based on the specific circumstances, USADA determined that a reduced sanction was appropriate.
Cachoeira’s four-month period of ineligibility began on October 12, 2019, the date her positive sample was collected.